Dr. Sara Ghandehari, MD

Dr. Ghandehari practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Ghandehari's NPI, 1245336270, was assigned on September 16, 2006. Dr. Ghandehari graduated from University of Illinois College of Medicine - Chicago in 2002. Dr. Ghandehari holds California license A87240.

Dr. Ghandehari's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Ghandehari's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Ghandehari to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ghandehari practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Ghandehari's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Ghandehari is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Ghandehari is licensed in California.

Dmand AI lists chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pleural effusion, pulmonary heart disease and tobacco use among the conditions Dr. Ghandehari treats.

CMS data shows 861 Medicare services from Dr. Ghandehari across 10 procedure codes in 2024, for 426 Medicare patients. Medicare paid $97,537 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 426 Medicare patients who saw Dr. Ghandehari in 2024. The largest group is 65 to 74, with 181 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 3.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ghandehari's median patient age at 69, with 53% women.

In 2024, Dr. Ghandehari wrote 25 Medicare Part D claims. 60% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $8,278 in total drug cost. In 2022, CMS named 329 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Ghandehari for performance year 2024, reported as part of a group. Dr. Ghandehari accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ghandehari as offering telehealth.

Dmand AI links 2 papers to Dr. Ghandehari in 2020. Dr. Ghandehari's most frequent co-authors are Sanford H. Barsky, MD, Tamana Kaderi and Divya Narayanan, MD.

Dmand AI links Dr. Ghandehari to 1 clinical trial. Conditions studied include COVID-19 and Pneumonia, Viral.

CMS Open Payments shows 6 general payments to Dr. Ghandehari from 6 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 91% of the total. Gilead Sciences, Inc. paid the most, $1,400.

Dr. Ghandehari graduated from University of Illinois College of Medicine - Chicago in 2002. Dr. Ghandehari is a member of ACP.

Dr. Ghandehari is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.